IDiyas

For the Inventor, By the Inventor

Remscheid, Germany

Dmitry Zubov

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 9.8

ph-index = 7

Forward Citations = 89(Granted Patents)


Location History:

  • Cologne, DE (2004)
  • Köln, DE (2004)
  • Remscheid, DE (2012 - 2023)

Company Filing History:

goldMedal10 out of 378 
 
Bayer Pharma Aktiengesellschaft
 patents
silverMedal6 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
bronzeMedal3 out of 721 
 
Bayer Intellectual Property Gmbh
 patents
4. 1 out of 443 
 
The Broad Institute, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):
1. 12398120 - Substituted hydantoinamides as ADAMTS7 antagonists (2025-08-26),
2. 11667675 - MASP inhibitory compounds and uses thereof (2023-06-06),
3. 11337973 - Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors (2022-05-24),
4. 10722501 - Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof (2020-07-28),
5. 10300062 - Bicyclically substituted uracils and the use thereof (2019-05-28),
6. 9949978 - Bicyclically substituted uracils and the use thereof (2018-04-24),
7. 9949977 - Bicyclically substituted uracils and the use thereof (2018-04-24),
8. 9751843 - Substituted uracils and use thereof (2017-09-05),
9. 9695131 - Substituted uracils as chymase inhibitors (2017-07-04),
10. 9481672 - Bicyclically substituted uracils and the use thereof (2016-11-01),
11. 9051323 - Substituted imidazopyrimidines and triazolopyrimidines (2015-06-09),
12. 8987248 - Substituted piperidines as Par-1 antagonists (2015-03-24),
13. 8273752 - Substituted imidazopyrimidines and triazolopyrimidines (2012-09-25),
14. 8119663 - Heteroaryl-substituted piperidines (2012-02-21),
15. 6835381 - Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor (2004-12-28),

Title: Dmitry Zubov: Innovator in Pharmaceutical Chemistry

Introduction

Dmitry Zubov is a prominent inventor based in Remscheid, Germany, known for his significant contributions to pharmaceutical chemistry. With a total of 16 patents to his name, he has made remarkable advancements in the field, particularly in the development of compounds for treating cardiovascular diseases.

Latest Patents

Among his latest patents is the invention of substituted hydantoinamides as ADAMTS7 antagonists. This application focuses on the use of these compounds for the treatment and prevention of various cardiovascular diseases, including atherosclerosis and coronary artery disease. Another notable patent involves MASP inhibitory compounds, which are aimed at treating renal and cardiovascular disorders, as well as ischemia-reperfusion injuries. These innovations highlight his commitment to addressing critical health issues through scientific research.

Career Highlights

Dmitry Zubov has worked with renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Throughout his career, Zubov has collaborated with notable colleagues, including Katja Zimmermann and Heinrich Meier. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Dmitry Zubov's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of cardiovascular diseases. His contributions through patents and collaborations continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…